First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI s...

por Müller, Volkmar, Ruhnke, Markus, Hoffmann, Oliver, Grafe, Andrea, Tomé, Oliver, Fett, Werner, Bruch, Harald-Robert, Sommer-Joos, Ann-Katrin, Schneeweiss, Andreas
Publicado 2021

Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a G...

por Thill, Marc, Wimberger, Pauline, Grafe, Andrea, Klare, Peter, Luedtke-Heckenkamp, Kerstin, Reichert, Dietmar, Zaiss, Matthias, Ziegler-Löhr, Katja, Eckl, Tanja, Schneeweiss, Andreas
Publicado 2022